Germany· DE-A57-bd670606be4b0e95
Locacorten-Vioform
A medicinal product containing flumetasone pivalate, clioquinol, registered in Germany by Esteve Pharmaceuticals Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Flumetasone Pivalate, Clioquinol
- Manufacturer
- Esteve Pharmaceuticals Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Flumetasone pivalate, clioquinol in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFlumetasone 0.02% / Clioquinol 1% ear dropsAlliance Healthcare (Distribution) Ltd
- FinlandLocacorten VioformNovartis Pharma Stein AG
- CanadaLOCACORTEN VIOFORMENDO OPERATIONS LTD.
- SwedenLocacorten-Vioform 0,2 mg/ml + 10 mg/ml Örondroppar, lösningAmdipharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Bulgaria · Лоринден C
- Denmark · Locacorten - Vioform
- Finland · Locacorten-Vioform
- United Kingdom (Northern Ireland) · Flumetasone/Clioquinol Amdipharma Uk Limited, Locorten Vioform
- Lithuania · Lorinden C
- Latvia · Lorinden C
- Netherlands · Locacorten-Vioform
- Poland · Lorinden C
- Sweden · Locacorten-Vioform
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf786285-9f06-40ae-8449-baaed02b716d GET /v1/drugs/bf786285-9f06-40ae-8449-baaed02b716d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Cutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Flumetasone Pivalate, Clioquinol",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about flumetasone pivalate, clioquinol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.